• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

physiomolecular analysis of S100A6 in leukemia with MLL/AF4

Research Project

Project/Area Number 22591051
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Hematology
Research InstitutionNippon Medical School

Principal Investigator

INOKUCHI Kouichi  日本医科大学, 医学部, 教授 (10203267)

Project Period (FY) 2010 – 2012
Project Status Completed (Fiscal Year 2012)
Budget Amount *help
¥4,680,000 (Direct Cost: ¥3,600,000、Indirect Cost: ¥1,080,000)
Fiscal Year 2012: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
Fiscal Year 2011: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2010: ¥2,470,000 (Direct Cost: ¥1,900,000、Indirect Cost: ¥570,000)
KeywordsMLL/AF4 / S100A6 / TNFα / caspase / IL24 / FLT3ITD / AFF1 / TNF / FLT3-D835I / 達伝子導入マウス
Research Abstract

We showed that MLL-AF4-positive ALL cell lines are resistant to TNF-α. To examine the mechanism of resistance to TNF-α of MLL-AF4-positive leukemia, we focused on S100A6 as a possible factor. Upregulation of S100A6 expression and inhibition of the p53-caspase8-caspase 3 pathway were observed only in MLL-AF4-positive ALL cell lines in the presence of TNF-α. The effect of S100A6 on resistance to TNF-α by inhibition of the p53-caspase8-caspase 3 pathway of MLL-AF4-positive ALL cell lines were also confirmed by analysis using small interfering RNA against S100A6. This pathway was also confirmed in previously established MLL-AF4 transgenic mice. These results suggest that MLL-AF4-positive ALL escapes from TNF-α-mediated apoptosis by upregulation of S100A6 expression, followed by interfering with p53-caspase 8-caspase 3 pathway.

Report

(4 results)
  • 2012 Annual Research Report   Final Research Report ( PDF )
  • 2011 Annual Research Report
  • 2010 Annual Research Report
  • Research Products

    (34 results)

All 2013 2012 2011 2010 2009 2008

All Journal Article (13 results) (of which Peer Reviewed: 7 results) Presentation (19 results) Book (1 results) Patent(Industrial Property Rights) (1 results)

  • [Journal Article] Mutations of the epigenetics modifying gene (DNMT3a, TET2, IDH1/2) at diagnosis may induce FLT3-ITD at relapse in de novo acute myeloid leukemia2013

    • Author(s)
      Wakita S, Yamaguchi H, Omori I, Terada K, Ueda T, Manabe E, Kurosawa S, Iida S, Ibaraki T, Sato Y, Todoroki T, Hirakawa T, Ryoutokuji T, Arai K, Kitano T, Mitamura Y, Kosaka F, Dan K, Inokuchi K
    • Journal Title

      Leukemia

      Volume: 27 Pages: 1044-1052

    • Related Report
      2012 Final Research Report
  • [Journal Article] AAV-8 vector expressing IL-24 efficiently suppresses tumor growth mediated by specific mechanisms in MLL/AF4-positive ALL model mice2012

    • Author(s)
      Tamai H, Miyake K, Yamaguchi H, Takatori M, Dan K, Inokuchi K, Shimada T
    • Journal Title

      Blood

      Volume: 119 Pages: 64-71

    • Related Report
      2012 Final Research Report
  • [Journal Article] Disappearance of Both the <I>BCR/ABL1</I> Fusion Gene and the <I>JAK2</I>V617F Mutation with Dasatinib Therapy in a Patient with Imatinib-Resistant Chronic Myelogenous Leukemia2012

    • Author(s)
      Inokuchi K
    • Journal Title

      Journal of Clinical and Experimental Hematopathology

      Volume: 52 Issue: 2 Pages: 145-147

    • DOI

      10.3960/jslrt.52.145

    • NAID

      10031120441

    • ISSN
      1346-4280, 1880-9952
    • Related Report
      2012 Annual Research Report
    • Peer Reviewed
  • [Journal Article] AAV-8 vector expressing IL-24 efficiently suppresses tumor growth mediated by specific mechanisms in MLL/AF4-positive ALL model mice.2012

    • Author(s)
      Tamai, H.
    • Journal Title

      Blood

      Volume: 119 Issue: 1 Pages: 64-71

    • DOI

      10.1182/blood-2011-05-354050

    • Related Report
      2012 Annual Research Report 2011 Annual Research Report
    • Peer Reviewed
  • [Journal Article] RCSD1-ABL1-positive B lymphoblastic leukemia is sensitive to dexamethasone and tyrosine kinaseinhibitors and rapidly evolves clonally by chromosomal translocations2011

    • Author(s)
      Inokuchi K, Wakita S, Hirakawa T, Tamai H, Yokose N, Yamaguchi H, Dan K
    • Journal Title

      Int J Hematol

      Volume: 94 Pages: 255-60

    • Related Report
      2012 Final Research Report
  • [Journal Article] Resistance ofMLL-AFF1-positive acute lymphoblastic leukemia to tumor necrosisfactor-alpha is mediated by S100A6 upregulation2011

    • Author(s)
      Tamai H, Miyake K, Yamaguchi H, Takatori M, Dan K, Inokuchi K, Shimada T
    • Journal Title

      Blood Cancer Journal

      Volume: e38 Issue: 11 Pages: 1-7

    • DOI

      10.1038/bcj.2011.37

    • Related Report
      2012 Final Research Report 2011 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Importance of c-kit mutation detection method sensitivity in prognostic analyses of t(8;21)(q22;q22) acute myeloid leukemia2011

    • Author(s)
      Wakita S, Yamaguchi H, Miyake K, Mitamura Y, Kosaka F, Dan K, Inokuchi K
    • Journal Title

      Leukemia

      Volume: 25 Pages: 1423-1432

    • Related Report
      2012 Final Research Report
  • [Journal Article] RCSD1-ABL1-positive B lymphoblastic leukemia is sensitive to dexamethasone and tyrosine kinase inhibitors and rapidly evolves clonally by chromosomal translocations2011

    • Author(s)
      Inokuchi K, et al
    • Journal Title

      International Journal Hematology

      Volume: 94 Issue: 3 Pages: 255-260

    • DOI

      10.1007/s12185-011-0910-z

    • NAID

      10029694299

    • Related Report
      2011 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Activated K-ras protein accelerates human MLL/AF4-induced leukemo-Lymphomogenicity in a transgenic mouse model2011

    • Author(s)
      Tamai K, Inokuchi K, et al
    • Journal Title

      Leuekmia

      Volume: (Epub ahead of print)

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Seven-year follow-up of patients receiving imatinib for the treatment of Newly diagnosed chronic myelogenous leukemia by the TARGET system2011

    • Author(s)
      Tauchi T, Kizaki M, et al
    • Journal Title

      Leukemia Research

      Volume: 35 Pages: 585-590

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Importance of maintaining the relative dose intensity of CHOP-like regimens combined with rituximab in patients with diffuse large B-cell lymphoma2010

    • Author(s)
      Hirakawa T, Yamaguchi H, Yokose N, Gomi S, Inokuchi K, Dan K
    • Journal Title

      Ann Hematol

      Volume: 89 Pages: 897-904

    • Related Report
      2012 Final Research Report
  • [Journal Article] Identification of TINF2 gene mutations in adult Japanese patients With acquired bone marrow failure syndromes2010

    • Author(s)
      Yamaguchi H, Inokuchi K, et al
    • Journal Title

      British Journal Haematology

      Volume: 150 Pages: 725-727

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Multisteppathogenesis of leukemia via the MLL-AF4 chimeric gene/Flt3 gene tyrosine kinase domain (TKD)mutation-related enhancement of S100A6 expression2009

    • Author(s)
      Yamaguchi H, Hanawa H, Uchida N, Inamai M, Sawaguchi K, Mitamura Y, Shimada T, Dan K, Inokuchi K
    • Journal Title

      Exp Hematol

      Volume: 37 Pages: 701-714

    • Related Report
      2012 Final Research Report
  • [Presentation] Clinical study of nilotinib in CML-CP patients with imatinib resistance or intolerance. TSSG study2012

    • Author(s)
      Inokuchi k, et al
    • Organizer
      第74回日本血液学会学術集会
    • Place of Presentation
      京都
    • Related Report
      2012 Final Research Report
  • [Presentation] Inokuchi K : Inhibition of S100A6 induces GVL effects in MLL/AF4-positive ALL in human-PBMC-SCID mice model2012

    • Author(s)
      Tamai H, Yamaguchi H, Dan K
    • Organizer
      第74回日本血液学会学術集会
    • Place of Presentation
      京都
    • Related Report
      2012 Final Research Report
  • [Presentation] The prognostic impact of FLT3 mutations in acute promyelocytic leukemia2012

    • Author(s)
      Hirakawa T, et al
    • Organizer
      第74回日本血液学会学術集会
    • Place of Presentation
      京都
    • Related Report
      2012 Final Research Report
  • [Presentation] Analysis of JAK2/MPL mutations and clinical features among myeloproliferative neoplasms in Japan2012

    • Author(s)
      Okabe M, et al
    • Organizer
      第74回日本血液学会学術集会
    • Place of Presentation
      京都
    • Related Report
      2012 Final Research Report
  • [Presentation] Inhibition of S100A6 induces GVL effects in MLL/AF4-positive ALL in human-PBMC-SCID mice model.2012

    • Author(s)
      Tamai H
    • Organizer
      第74回日本血液学会学術集会
    • Place of Presentation
      京都
    • Related Report
      2012 Annual Research Report
  • [Presentation] Clinical study of nilotinib in CML-CP patients with imatinib resistance or intolerance. TSSG study.2012

    • Author(s)
      Inokuchi K
    • Organizer
      第74回日本血液学会学術集会
    • Place of Presentation
      京都
    • Related Report
      2012 Annual Research Report
  • [Presentation] The clinical features and prognostic impact of DNMT3A gene mutation in Japanese patients with de novo AML2011

    • Author(s)
      Ryoutokuji T, et al
    • Organizer
      The 53^<th> annual meeting of the American Society of Hematology
    • Place of Presentation
      San Diego
    • Related Report
      2012 Final Research Report
  • [Presentation] Gene mutations in paired initial presentation and relapse samples from acute myeloid leukemia patients2011

    • Author(s)
      Wakita S, et al
    • Organizer
      The 53^<th> annual meeting of the American Society of Hematology
    • Place of Presentation
      San Diego
    • Related Report
      2012 Final Research Report
  • [Presentation] Telomerase activity is useful for the screening of cryptic and late onset dyskeratosis congenital and evaluation of the treatment response to anabolic steroids for their bone marrow failure2011

    • Author(s)
      Takeuchi J, et al
    • Organizer
      The 16^<th> congress ofthe European Hematology Association
    • Place of Presentation
      London
    • Related Report
      2012 Final Research Report
  • [Presentation] Gene mutation in paired initial presentation and relapse samples from acute myeloid leukemia2011

    • Author(s)
      Wakita H, et al
    • Organizer
      The 16^<th> congress of the European Hematology Association
    • Place of Presentation
      London
    • Related Report
      2012 Final Research Report
  • [Presentation] The clinical features of DNMT3A gene mutation in Japanese patients with de novo AML2011

    • Author(s)
      Ryoutokuji T, et al
    • Organizer
      第73回日本血液学会学術集会
    • Place of Presentation
      名古屋
    • Related Report
      2012 Final Research Report
  • [Presentation] Clinical course and molecular characteristics of RCSD1-ABL1 positive pre-B lymphoblastic leukemia2011

    • Author(s)
      Wakita S, et al
    • Organizer
      第73回日本血液学会学術集会
    • Place of Presentation
      名古屋
    • Related Report
      2012 Final Research Report
  • [Presentation] Activated K-ras protein accelerates human MLL/AF4-induced leukemo-lymphomogenicity in a transgenic mouse model2010

    • Author(s)
      Tamai H, Inokuchi K, et al.
    • Organizer
      第52回アメリカ血液学会
    • Place of Presentation
      Orlando, Florida, USA
    • Year and Date
      2010-12-04
    • Related Report
      2010 Annual Research Report
  • [Presentation] MLL/AF4 positive acute lymphoblastic leukemia has resistance to tumor necrosis factor-alfa caused by up-reguration of S100A62010

    • Author(s)
      Tamai H, et al
    • Organizer
      The 52&th annual meeting of the American Society of Hematology
    • Place of Presentation
      Orlando Florida
    • Related Report
      2012 Final Research Report
  • [Presentation] The activated K-RAS protein accelerates human drived-MLL/AF4 induced leukemo-lymphmogenicity in transgenic mice model2010

    • Author(s)
      Tamai H, et al
    • Organizer
      The 52^<th> annual meeting of the American Society of Hematology
    • Place of Presentation
      Orlando Florida
    • Related Report
      2012 Final Research Report
  • [Presentation] C-kit mutation is a significant prognostic factor of t(8;21) AML: Importance of highly sensitive Q-probe method2010

    • Author(s)
      Wakita S, et al
    • Organizer
      15^<th>.European Hematology Association
    • Place of Presentation
      Barcelona, Spain
    • Related Report
      2012 Final Research Report
  • [Presentation] Establishment and Characterization of A New Lymphoid Malignancy Mouse Model Induced by the combination of MLL/AF4 and K-RAS2010

    • Author(s)
      玉井勇人
    • Organizer
      第72回日本血液学会総会
    • Place of Presentation
      横浜
    • Related Report
      2012 Final Research Report
  • [Presentation] Gene Therapy of Acute Lymphoblastic Leukemia with MLL/AF4 Using AAV8-IL242010

    • Author(s)
      玉井勇人
    • Organizer
      第72回日本血液学会総会
    • Place of Presentation
      横浜
    • Related Report
      2012 Final Research Report
  • [Presentation] Establishment of Aggressive MLL/AF4Induced Lymphoma Model Mice ThroughUP-Regulation of HOXA9 and S100A6Expression2010

    • Author(s)
      玉井勇人
    • Organizer
      第16回日本遺伝子治療学会
    • Place of Presentation
      宇都宮
    • Related Report
      2012 Final Research Report
  • [Book] 血液・造血器疾患のマネージメント2011

    • Author(s)
      猪口孝一、室井一男, 他
    • Total Pages
      219
    • Publisher
      医薬ジャーナル社
    • Related Report
      2010 Annual Research Report
  • [Patent(Industrial Property Rights)] ヒト MLL/AF4 融合遺伝子導入トランスジェニック非ヒト動物2008

    • Inventor(s)
      猪口孝一
    • Industrial Property Rights Holder
      日本医科大学医学部
    • Industrial Property Number
      2008-319606
    • Filing Date
      2008-12-16
    • Related Report
      2012 Final Research Report

URL: 

Published: 2010-08-23   Modified: 2019-07-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi